Plaintiffs who filed lawsuits over kidney injuries allegedly caused by proton pump inhibitor (PPI) heartburn medications like Nexium (esomeprazole) have filed a motion seeking consolidation of the complaints in the Middle District of Louisiana.
Free Confidential Lawsuit Evaluation: If you or a loved one developed kidney disease, nephritis, renal failure or other kidney damage after taking a proton pump inhibitor (PPI) heartburn medication, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.
What’s the Problem?
October 20, 2016 – According to a motion filed with the U.S. Judicial Panel for Multidistrict Litigation (JPML) on Monday, at least 15 PPI lawsuits involving injuries including acute interstitial nephritis, chronic kidney disease and kidney failure are currently pending in courts across the U.S. However, the plaintiffs argue that thousands of additional cases are under investigation, and many more lawsuits are likely to be filed in the coming weeks and months.
In addition to Nexium, other proton pump inhibitors include:
- Aciphex (rabeprazole)
- Protonix (pantoprazole)
- Prevacid (lansoprazole)
- Zegerid (omeprazole / sodium bicarbonate)
- Dexilant (dexlansoprazole)
- Prilosec (omeprazole)
- Vimovo (esomeprazole and naproxen)
Due to their ability to block secretion of acid into the stomach, proton pump inhibitors may increase the risk of long-term kidney damage, according to a study published in JAMA Internal Medicine in February 2016. For the study, researchers looked at the medical records of over 10,000 patients treated in community-based settings, and found a 20-50% increased risk of chronic kidney disease (CKD) among patients who took the drugs. The association also turned up when they examined the records of more than 248,000 people treated in a Pennsylvania hospital system.
PPI lawsuits allege that manufacturers failed to adequately warn the public and medical community about the drugs’ potential to cause kidney damage. Plaintiffs allege that without the creation of an MDL, there exists “the possibility of inconsistent pretrial rulings exists, especially with respect to the proper scope and extent of discovery, causation, and other factual and legal issues.”
The proposed litigation is In re: Proton-Pump Inhibitor Products Liability Litigation – MDL No. 2757.
Do I Have a Proton Pump Inhibitor Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in PPI lawsuits. We are handling individual litigation nationwide and currently accepting new kidney injury cases in all 50 states.
Free Case Evaluation: Again, if you suffered any form of kidney damage after taking a proton pump inhibitor, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.